Taken together, our data demonstrate that allosteric inhibition of the CBF complex phenocopies genetic depletion of either of the two subunits, opening a novel therapeutic avenue in B-ALL. This evidence concerns the gene CEBPZ and precursor B-cell acute lymphoblastic leukemia.